China has classified tiletamine — a veterinary anaesthetic widely used in pet surgeries — as a controlled substance effective July 1, 2026, placing it under the same regulatory framework as fentanyl after a sharp rise in recreational inhalation among young people. The move follows documented abuse across entertainment venues in multiple cities, exposing a critical gap in the country's narcotics legislation.

What tiletamine is and why it was misused

Tiletamine shares a chemical structure with ketamine — colloquially known as 'K powder' — and was primarily used as a surgical anaesthetic for animals such as cats and dogs. Because it was not previously listed as a controlled substance, it existed in a regulatory vacuum that made it easily accessible. The drug can be vaporised in so-called 'heady e-cigarettes,' delivering dissociative highs including visual and auditory hallucinations and loss of conscious awareness.

Scale of the problem

The speed at which tiletamine spread underscores how quickly unscheduled substances can be weaponised once a loophole is identified. According to a paper published in the fifth issue of the 2026 Policing Studies in Chinese, 'from November 2025 to early January 2026, in the city of Shenyang alone, 1,605 individuals were investigated and educated for the abuse of tiletamine.' The drug reportedly became especially prevalent in entertainment venues including billiard halls, discos, nightclubs, and bars.

Regulatory response

The National Narcotics Control Commission Office and the Ministry of Public Security moved to close the loophole by scheduling tiletamine at the strictest tier of controlled substances, on par with opioids like fentanyl. The classification applies nationwide and carries the full weight of China's narcotics enforcement apparatus. Authorities in cities including Shenyang in Northeast China and Shanghai had already been tracking cases ahead of the formal ban.

Why it matters

The tiletamine episode illustrates a recurring pattern in drug regulation: the lag between the emergence of a novel psychoactive substance and its formal scheduling creates windows of mass abuse. The fact that a veterinary compound — not a synthetic designer drug — became a youth-facing recreational substance through e-cigarette technology signals that regulators must broaden surveillance beyond traditional narcotics categories. The Shanghai Municipal People's Procuratorate had reportedly flagged related cases prior to the national ban.

What's next

With tiletamine now scheduled, enforcement agencies will likely intensify scrutiny of veterinary supply chains and e-cigarette distribution networks. The broader question is whether similar compounds with dissociative properties — particularly those not yet on any controlled list — will fill the gap. Authorities and public health researchers will be watching abuse trend data from cities like Shenyang and Shanghai to assess whether the ban produces the intended deterrent effect.